Head of Investor Relations
Maravai Lifesciences Holdings, Inc. (MRVI)Equibles does not estimate personal net worth.
Get an email with a short summary when Maravai Lifesciences Holdings, Inc. publishes a filing, an earnings call transcript or a press release.
Get MRVI alertsDeb Hart is recorded as Head of Investor Relations at Maravai Lifesciences Holdings, Inc. (MRVI). Deb Hart has spoken on 10 earnings calls across 1 company, most recently for Maravai Lifesciences Holdings, Inc. on November 4, 2026. Maravai Lifesciences Holdings, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Maravai Lifesciences Holdings, Inc. includes Bernd Brust (CEO and Board Member), William "Trey" Martin, III (CEO and Board Member), William E. Martin III (CEO) and 7 others.
“The press release and the slides that accompany today's call are available at investors.maravi.com. As you can see from the agenda on slide two, our CEO, Bernd Brust, will provide a business update, and our CFO, Raj Asapoda, will review our financial results.”
“The press release and slides accompanying today's call are available at investors.maravai.com. As you can see from the agenda on slide two, our CEO, Burnt Breast, will provide a business update, and our CFO, Raj Asapoda, will review our financial results.”
“The press release and slides accompanying today's call are posted on our website and available at investors.maravai.com. As you can see from the agenda on slide two, our CEO, Vern Brust, will provide a business update, and our CFO, Raj Asapoda, will review our financial results.”
“The slides accompanying today's call are posted on our website and available at investors.maravai.com. As you can see from the agenda on Slide 2, Trey Martin, Chief Executive Officer, and Kevin Herde, Chief Financial Officer, are joining me today.”
“Our press release and the slides accompanying today's call are posted on our website and available at investors.maravai.com. As you can see from our agenda on Slide 2, Trey Martin, Chief Executive Officer; and Kevin Herde, Chief Financial Officer, are joining me today.”
Biotechnology · Healthcare
Head of Investor Relations
